Target Validation
What Is the Difference Between a Drug Target and a Biomarker? A Guide for Biotech Investors
Two terms that appear in almost every substantive description of a biotech company’s drug development program are drug target and biomarker. They are related but distinct — and confusing the two is one of the most common sources of misinterpretation when retail investors read clinical trial descriptions, pipeline summaries, or drug mechanism explanations. Understanding the…
What Is Preclinical Research? The Science That Happens Before Human Trials
Every drug that has ever entered a human clinical trial first passed through a preclinical research phase — a body of laboratory and animal studies conducted before any human being receives the compound. Preclinical research is where most drugs fail, often silently, without ever generating a press release or a stock move. For investors in…
